Bank of Montreal’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-500
| Closed | -$1K | – | 5251 |
|
|
2019
Q1 | $1K | Buy |
+500
| New | +$407 | ﹤0.01% | 4260 |
|
|
2018
Q3 | – | Sell |
-4,000
| Closed | -$9K | – | 5051 |
|
|
2018
Q2 | $9K | Sell |
4,000
-4,000
| -50% | -$11.6K | ﹤0.01% | 4003 |
|
|
2018
Q1 | $25K | Hold |
8,000
| – | – | ﹤0.01% | 3500 |
|
|
2017
Q4 | $33K | Hold |
8,000
| – | – | ﹤0.01% | 3430 |
|
|
2017
Q3 | $36K | Sell |
8,000
-160
| -2% | -$648 | ﹤0.01% | 3355 |
|
|
2017
Q2 | $28K | Sell |
8,160
-5,000
| -38% | -$20.7K | ﹤0.01% | 3422 |
|
|
2017
Q1 | $121K | Hold |
13,160
| – | – | ﹤0.01% | 2727 |
|
|
2016
Q4 | $111K | Hold |
13,160
| – | – | ﹤0.01% | 2783 |
|
|
2016
Q3 | $151K | Hold |
13,160
| – | – | ﹤0.01% | 2567 |
|
|
2016
Q2 | $162K | Hold |
13,160
| – | – | ﹤0.01% | 2578 |
|
|
2016
Q1 | $133K | Sell |
13,160
-840
| -6% | -$9.86K | ﹤0.01% | 2674 |
|
|
2015
Q4 | $316K | Sell |
14,000
-3,000
| -18% | -$61.5K | ﹤0.01% | 2182 |
|
|
2015
Q3 | $282K | Hold |
17,000
| – | – | ﹤0.01% | 2103 |
|
|
2015
Q2 | $383K | Sell |
17,000
-3,095
| -15% | -$76.3K | ﹤0.01% | 2103 |
|
|
2015
Q1 | $518K | Buy |
20,095
+4,904
| +32% | +$124K | ﹤0.01% | 1914 |
|
|
2014
Q4 | $330K | Buy |
15,191
+4,191
| +38% | +$85.8K | ﹤0.01% | 2255 |
|
|
2014
Q3 | $208K | Sell |
11,000
-2,120
| -16% | -$42.6K | ﹤0.01% | 2524 |
|
|
2014
Q2 | $306K | Buy |
13,120
+2,120
| +19% | +$52.3K | ﹤0.01% | 2331 |
|
|
2014
Q1 | $370K | Buy |
11,000
+4,000
| +57% | +$135K | ﹤0.01% | 2210 |
|
|
2013
Q4 | $207K | Buy |
+7,000
| New | +$128K | ﹤0.01% | 2229 |
|
Bank of Montreal's OMED Position: Q2 2019 in Review
Bank of Montreal sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 500 shares — an estimated $1K sold.
Bank of Montreal first reported a position in OMED in Q4 2013 and held it in 20 quarters. The position peaked at $518K in Q1 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.
- Bank of Montreal reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
- Bank of Montreal sold 500 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1K.
- Bank of Montreal first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2013 and held it in 20 quarters.
- Bank of Montreal's OncoMed Pharmaceuticals, Inc. position peaked at $518K in Q1 2015.
- 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.
Based on Bank of Montreal's 13F filing for Q2 2019, filed 9 Aug 2019.